Sarepta Therapeutics to Present at Upcoming Investor Conferences

On March 2, 2022 Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, reported that senior management will participate in fireside chats at three upcoming virtual investor conferences (Press release, Sarepta Therapeutics, MAR 2, 2022, View Source [SID1234609480]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 42nd Annual Health Care Conference on Wednesday, March 9, 2022 at 2:10 p.m. E.T.
Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 3:20 p.m. E.T.
Guggenheim 3rd Annual Genomic Medicines and Rare Disease Day on Thursday, March 31, 2022 at 12 p.m. E.T.
The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.